U-CAN aims to create a well-structured multidisciplinary clinical information database and a biobank on a large number of cancer patients to enable translational and clinical cancer research. The project began in 2010 and collects data from hospitals in the regions of Uppsala, Umeå, Gävle, Falun, Karlstad, Eskilstuna and Västerås in Sweden. The patients recruited to the U-CAN sample collection area include adults diagnosed with any of the selected cancer types, living primarily in the counties of Uppsala and Vasterbotten or who have been referred to two university hospitals for diagnosis, treatment and/or follow-up from surrounding counties. As of the end of 2024, almost 30,000 participants have been included in the study and are assessed at diagnosis and prior to any impact on the tumour (e.g. surgery, radiation or drug treatment). Participants are followed up at several points throughout their cancer treatment and at first relapse or evidence of progressive disease.
Study design
Biobank, Registry
Number of participants at first data collection
29,207 (participants, as of 2024)
Recruitment is ongoing
Age at first data collection
≥ 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2010
Primary Institutions
KTH Royal Institute of Technology (Kungliga Tekniska högskolan)
Stockholm University (Stockholms universitet)
Umeå University (Umeå Universitet)
Uppsala University (Uppsala universitet, UU)
Profile paper DOI
Funders
County Council of Uppsala
Government of the Kingdom of Sweden (Konungariket Sveriges regering)
Uppsala University
Ongoing?
Yes
Data types collected
Engagement
Keywords